Suregraft 0.25 Tablet

Suregraft 0.25 Tablet belongs to the group of medicine called ‘anti-cancer’. It is primarily used to treat breast cancer, pancreatic cancer, lung cancer and kidney cancer. Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen. Pancreatic cancer is described as a cancerous growth in the pancreas which normally begins in the cells that generate the juices that help break down food and the hormones which help in controlling blood sugar levels. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. 

Suregraft 0.25 Tablet contains 'Everolimus' which belongs to the group of medicines known as 'kinase inhibitors'. It works by decreases the activity of the immune system of the body and prevents rejection of the transplanted organ. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.

Take Suregraft 0.25 Tablet as prescribed by your doctor. You are advised to take Suregraft 0.25 Tablet for as long as your doctor has prescribed it for you depending on your medical conditions. You may experience weakness, infection, sinus inflammation, cough, diarrhea, fever, fatigue, otitis media (infection of the ear), stomatitis (Inflammation of the mouth) and upper respiratory tract infection. Most of these side effects of Suregraft 0.25 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

To treat your condition effectually, continue taking Suregraft 0.25 Tablet for as long as your doctor has prescribed. If you are known to be allergic to Suregraft 0.25 Tablet or any other medicines, please tell your doctor. Do not take Suregraft 0.25 Tablet if you are pregnant or planning for pregnancy as Suregraft 0.25 Tablet may harm the unborn baby. Suregraft 0.25 Tablet should not be taken by breastfeeding mothers as it may cause harm to the newborn baby. Suregraft 0.25 Tablet causes tiredness, thus, it is advisable not to drive unless you are alert. Elderly people are more sensitive to medicine so they may adjust the dosage according to their condition.

Suregraft 0.25 Tablet is used in the treatment of Breast cancer, pancreatic cancer, lung cancer, and kidney cancer. The detailed uses of Suregraft 0.25 Tablet are as follows:

• Cancer Treatment: Suregraft 0.25 Tablet is used for various cancers, including advanced hormone receptor-positive breast cancer, pancreatic neuroendocrine tumors, and neuroendocrine tumors of the stomach, lungs, and intestines that cannot be treated surgically.
• Kidney Cancer Management: Suregraft 0.25 Tablet is used in advanced renal cell carcinoma when other treatments have failed.
• Organ Transplant Rejection Prevention: Suregraft 0.25 Tablet helps prevent rejection in kidney and liver transplant patients by suppressing the immune system.
• Tuberous Sclerosis Complex (TSC)-Related Tumors: Suregraft 0.25 Tablet is indicated for treating certain benign tumors associated with TSC, such as subependymal giant cell astrocytoma (SEGA) and renal angiomyolipoma.
• Immunosuppressive Therapy: As an mTOR inhibitor, Suregraft 0.25 Tablet reduces the activity of immune cells, helping manage autoimmune conditions and prevent transplant-related complications.

• Suregraft 0.25 Tablet can be taken with or without food.
• It is recommended to take Suregraft 0.25 Tablet once daily at the same time each day or as advised by your doctor.
• Swallow Suregraft 0.25 Tablet as a whole with a glass of water.
• Do not crush, break, or chew it.

Suregraft 0.25 Tablet is indicated to the patients dealing with breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Suregraft 0.25 Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreases the activity of the immune system of the body and prevents rejection of the transplanted organ. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumors in the brain or kidney.

If you are known to be allergic to Suregraft 0.25 Tablet or any other medicines, please tell your doctor. Suregraft 0.25 Tablet should not be taken in the conditions like liver disease, diabetes and high level of cholesterol. Do not take Suregraft 0.25 Tablet if you have recent surgery, infection and hepatitis B. Suregraft 0.25 Tablet may weaken your immune system, inform your doctor before taking Suregraft 0.25 Tablet. Suregraft 0.25 Tablet may also impair your kidney function. Therefore, monitor your kidney function regularly while taking Suregraft 0.25 Tablet. Suregraft 0.25 Tablet may cause cough, fever and shortness of breathing, thereby inform your doctor while taking your Suregraft 0.25 Tablet. Suregraft 0.25 Tablet may cause skin cancer, if you observe night sweating, weight loss, or change in color and size of the mole inform your doctor. Do not take Suregraft 0.25 Tablet if you are pregnant or planning for pregnancy as Suregraft 0.25 Tablet may harm the unborn baby. Suregraft 0.25 Tablet should not be taken by breastfeeding mothers as it may cause harm to the newborn baby. Suregraft 0.25 Tablet causes tiredness, thus, it is advisable not to drive unless you are alert. Elderly people are more sensitive to medicine so they may adjust the dosage according to their condition.